188 related articles for article (PubMed ID: 15639607)
1. A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
Kanamori T; Tsujikawa K; Ohmae Y; Iwata YT; Inoue H; Kishi T; Nakahama T; Inouye Y
Forensic Sci Int; 2005 Mar; 148(2-3):131-7. PubMed ID: 15639607
[TBL] [Abstract][Full Text] [Related]
2. Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
Carmo H; Hengstler JG; de Boer D; Ringel M; Remião F; Carvalho F; Fernandes E; dos Reys LA; Oesch F; de Lourdes Bastos M
Toxicology; 2005 Jan; 206(1):75-89. PubMed ID: 15590110
[TBL] [Abstract][Full Text] [Related]
3. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.
Kanamori T; Inoue H; Iwata Y; Ohmae Y; Kishi T
J Anal Toxicol; 2002 Mar; 26(2):61-6. PubMed ID: 11916016
[TBL] [Abstract][Full Text] [Related]
4. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Bork WR; Maurer HH
J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
[TBL] [Abstract][Full Text] [Related]
5. Incorporation and retention of radiolabeled S-(+)-and R-(-)-methamphetamine and S(+)- and R(-)-N-(n-butyl)-amphetamine in mouse hair after systemic administration.
Stout PR; Claffey DJ; Ruth JA
Drug Metab Dispos; 2000 Mar; 28(3):286-91. PubMed ID: 10681372
[TBL] [Abstract][Full Text] [Related]
6. Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration.
Rohanová M; Pálenícek T; Balíková M
Toxicol Lett; 2008 Apr; 178(1):29-36. PubMed ID: 18339493
[TBL] [Abstract][Full Text] [Related]
7. In vivo metabolism of 2,5-dimethoxy-4-propylthiophenethylamine in rat.
Kanamori T; Kuwayama K; Tsujikawa K; Miyaguchi H; Iwata YT; Inoue H; Kishi T
Xenobiotica; 2007 Jun; 37(6):679-92. PubMed ID: 17614010
[TBL] [Abstract][Full Text] [Related]
8. The fate of p-bromo-methylamphetamine (V-111) in the body.
Magyar K; Tekes K; Zólyomi G; Szüts T; Knoll J
Acta Physiol Acad Sci Hung; 1981; 57(3):285-307. PubMed ID: 7304194
[TBL] [Abstract][Full Text] [Related]
9. [The effect of ethanol on the metabolism of methamphetamine].
Ochiai T
Nihon Hoigaku Zasshi; 1992 Feb; 46(1):32-48. PubMed ID: 1597931
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of methamphetamine, amphetamine and p-hydroxymethamphetamine by rat-liver microsomal preparations in vitro.
Yamamoto T; Takano R; Egashira T; Yamanaka Y
Xenobiotica; 1984 Nov; 14(11):867-75. PubMed ID: 6506759
[TBL] [Abstract][Full Text] [Related]
11. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Theobald DS; Staack RF; Puetz M; Maurer HH
J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
[TBL] [Abstract][Full Text] [Related]
12. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-beta-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry.
Theobald DS; Fritschi G; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):374-7. PubMed ID: 16978931
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 4-bromo-2,5-dimethoxyphenethylamine abuser's urine: identification and quantitation of urinary metabolites.
Kanamori T; Nagasawa K; Kuwayama K; Tsujikawa K; Iwata YT; Inoue H
J Forensic Sci; 2013 Jan; 58(1):279-87. PubMed ID: 23066942
[TBL] [Abstract][Full Text] [Related]
14. Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry.
Rohanova M; Balikova M
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S429-30. PubMed ID: 19261515
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.
Carmo H; de Boer D; Remião F; Carvalho F; dos Reys LA; de Lourdes Bastos M
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):143-52. PubMed ID: 15522713
[TBL] [Abstract][Full Text] [Related]
16. Comparison of amphetamine metabolism using isolated hepatocytes from five species including human.
Green CE; LeValley SE; Tyson CA
J Pharmacol Exp Ther; 1986 Jun; 237(3):931-6. PubMed ID: 3712286
[TBL] [Abstract][Full Text] [Related]
17. Determination of 4-hydroxy-3-methoxymethamphetamine as a metabolite of methamphetamine in rats and human liver microsomes using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry.
Kuwayama K; Tsujikawa K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
J Anal Toxicol; 2009 Jun; 33(5):266-71. PubMed ID: 19671246
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
19. Biotransformation of deramciclane in primary hepatocytes of rat, mouse, rabbit, dog, and human.
Monostory K; Kohalmy K; Ludányi K; Czira G; Holly S; Vereczkey L; Urmös I; Klebovich I; Kóbori L
Drug Metab Dispos; 2005 Nov; 33(11):1708-16. PubMed ID: 16118331
[TBL] [Abstract][Full Text] [Related]
20. Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-beta- phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques.
Theobald DS; Maurer HH
J Mass Spectrom; 2006 Nov; 41(11):1509-19. PubMed ID: 17103384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
